William Mangham
Neurological Surgery · New Orleans, LANPI 1609230788
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,882 of the $2,770 with a category attached, or 67.9%. 11 manufacturers reported payments, led by ALON Medical Technology at 35.5% of the total. 2025 is the largest year on record at $1,309, 2.8 times the $475 reported in 2023. That places this record below the midpoint for neurological surgery clinicians in LA, where the typical reported total is $5,328.
Across 26 payments — averaging $106.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ALON Medical Technology$984
- Globus Medical$866
- Spine Wave, Inc.$337
- Arthrex$210
- Johnson & Johnson$200
- Acera Surgical, Inc.$42
- plus $131 from 5 others
What the payments were for
- Travel & lodging$1,88268%
- Food & beverage$88932%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ALON Medical Technology | 6 | $984 |
| Globus Medical | 4 | $866 |
| Spine Wave, Inc. | 3 | $337 |
| Arthrex | 3 | $210 |
| Johnson & Johnson | 4 | $200 |
| Acera Surgical, Inc. | 1 | $42 |
| Augmedics Inc. | 1 | $34 |
| Innovation Technologies Inc | 1 | $31 |
| Medtronic | 1 | $28 |
| Zimvie Inc. | 1 | $24 |
| Sanara Medtech Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,770 in reported general payments places this provider in the 35th percentile of 116 neurological surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tizanidine Hcl | 14 | $313 |
| Pregabalin | 21 | $273 |
| Gabapentin | 26 | $249 |
| Cyclobenzaprine Hcl | 16 | $218 |
| Methocarbamol | 19 | $168 |
| Methylprednisolone | 14 | $132 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in New Orleans
- Gabriel TenderNew Orleans$255K
- Christopher MaulucciNew Orleans$134K
- Kendrick JohnsonNew Orleans$82K
- Tyler ScullenNew Orleans$51K
- Aaron DumontNew Orleans$44K
- Sassan KeshavarziNew Orleans$34K
- Lora KahnNew Orleans$24K
- Miguel MelgarNew Orleans$20K
- Johnny DelashawNew Orleans$19K
- Adam PodetNew Orleans$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.